BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6931575)

  • 1. The treatment of glomerulonephritis.
    Kincaid-Smith P
    Aust N Z J Med; 1980 Jun; 10(3):340-5. PubMed ID: 6931575
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary glomerular disease: to treat or not to treat.
    Donadio JV
    Contrib Nephrol; 1982; 33():86-103. PubMed ID: 7116871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current trends in the treatment of primary glomerulonephritis].
    Ponticelli C; Passerini P
    Minerva Urol Nefrol; 1984; 36(4 Suppl):7-13. PubMed ID: 6398922
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C; Banfi G; Imbasciati E; Tarantino A
    Contrib Nephrol; 1982; (34):33-54. PubMed ID: 6293765
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of glomerular diseases.
    Simon NM; Rosenberg MJ
    Med Clin North Am; 1978 Nov; 62(6):1157-81. PubMed ID: 153991
    [No Abstract]   [Full Text] [Related]  

  • 6. Current therapeutic strategies in glomerulonephritis.
    Woo KT
    Ann Acad Med Singap; 1999 Mar; 28(2):272-8. PubMed ID: 10497681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.
    Grupe WE; Heymann W
    Am J Dis Child; 1966 Nov; 112(5):448-58. PubMed ID: 5917978
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF; McDonald I; Fairley KF; Kincaid-Smith PS
    Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response.
    Arbus GS; Poucell S; Bacheyie GS; Baumal R
    J Pediatr; 1982 Jul; 101(1):40-5. PubMed ID: 7045316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
    Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
    Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.
    Walker RG; Kincaid-Smith P
    Nephron; 1990; 54(2):117-21. PubMed ID: 2179754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
    Martinelli R; Pereira LJ; Silva OM; Okumura AS; Rocha H
    Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
    Futrakul P
    Int J Pediatr Nephrol; 1980 Mar; 1(1):18-21. PubMed ID: 7343523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focal-segmental sclerosis. Importance of early diagnosis].
    Balli F; Genova R
    Minerva Pediatr; 1977 Mar; 29(8):551-4. PubMed ID: 865436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
    Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
    Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
    [No Abstract]   [Full Text] [Related]  

  • 18. [Corticosteroid therapy of compensated intracapillary glomerulonephritis].
    Ratner MIa; Tomilina NA; Samokhina NM
    Klin Med (Mosk); 1982 Apr; 60(4):72-6. PubMed ID: 7098396
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment of the chronic idiopathic glomerulopathies.
    Lindeman RD
    Postgrad Med; 1977 Sep; 62(3):135-43. PubMed ID: 302444
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.